Use of Nonrecommended Antivirals Among Medicare Beneficiaries With HIV
This cross-sectional study examines contemporary evidence on the extent to which Medicare beneficiaries with HIV fill older, more toxic antivirals as part of their antiretroviral therapy.
Authors
- Jacqueline T. Chu
- José F. Figueroa (ORCID: https://orcid.org/0000-0003-3811-257X)
- Jessica Phelan (ORCID: https://orcid.org/0000-0001-7008-7744)
- Endel John Orav (ORCID: https://orcid.org/0000-0002-8886-7252)
- Rajesh T. Gandhi (ORCID: https://orcid.org/0000-0002-9701-6062)
- Dannie Dai
- Emily P. Hyle (ORCID: https://orcid.org/0000-0001-8721-106X)
- Ciara Duggan
- Florence Ebem
- Grace Luu
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.8296
- Citations
- 1
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Institutes of Health
- Center for AIDS Research, University of Washington
- National Heart, Lung, and Blood Institute
- National Institute of Mental Health
- National Cancer Institute
- National Institute of Nursing Research
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Child Health and Human Development
- National Institute on Minority Health and Health Disparities